JDOC vs. XLVI
JDOC (Jpmorgan Healthcare Leaders ETF) and XLVI (State Street Health Care Select Sector SPDR Premium Income ETF) are both exchange-traded funds - JDOC is a Health & Biotech Equities fund actively managed by JPMorgan, while XLVI is a Derivative Income fund actively managed by State Street. Both are actively managed. Over the past year, JDOC returned 23.57% vs 22.96% for XLVI. Their correlation of 0.88 means they have usually moved in the same direction. JDOC charges 0.65%/yr vs 0.35%/yr for XLVI.
Performance
JDOC vs. XLVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JDOC achieves a 4.29% return, which is significantly lower than XLVI's 6.89% return.
JDOC
- 1D
- -0.50%
- 1M
- -2.51%
- 6M
- 2.15%
- YTD
- 4.29%
- 1Y
- 23.57%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 9.54%
XLVI
- 1D
- -0.20%
- 1M
- 0.97%
- 6M
- 6.00%
- YTD
- 6.89%
- 1Y
- 22.96%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 19.93%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $21.20K | $19.99K | $31.46K | |
| $940.40K | $699.80K | $484.44K |
JDOC vs. XLVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
JDOC Jpmorgan Healthcare Leaders ETF | 4.29% | 16.23% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 6.89% | 12.41% |
Correlation
The correlation between JDOC and XLVI is 0.88, meaning they have usually moved in the same direction, including during past declines.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.88 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2025 | 0.88 |
The correlation between JDOC and XLVI has been stable across timeframes, ranging from 0.88 to 0.88 - a consistent structural relationship.
JDOC vs. XLVI - Sectors Allocation Comparison
Sectors
JDOC
XLVI
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
JDOC
XLVI
Basic Materials
JDOC
-
XLVI
-
Communication Services
JDOC
-
XLVI
-
Consumer Cyclical
JDOC
-
XLVI
-
Consumer Defensive
JDOC
-
XLVI
-
Energy
JDOC
-
XLVI
-
Financial Services
JDOC
-
XLVI
Industrials
JDOC
-
XLVI
-
Real Estate
JDOC
-
XLVI
-
Technology
JDOC
-
XLVI
-
Utilities
JDOC
-
XLVI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JDOC vs. XLVI — Risk / Return Rank
JDOC
XLVI
JDOC vs. XLVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Jpmorgan Healthcare Leaders ETF (JDOC) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JDOC | XLVI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.55 | ||
| Sortino ratioReturn per unit of downside risk | -0.70 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 1.41 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 2.44 | 2.83 | -0.39 |
| Martin ratioReturn relative to average drawdown | 6.25 | 8.00 | -1.75 |
Loading charts...
Drawdowns
JDOC vs. XLVI - Drawdown Comparison
The maximum JDOC drawdown since its inception was -20.87%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for JDOC and XLVI.
Loading charts...
Drawdown Indicators
| JDOC | XLVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -20.87% | -8.14% | -12.73% |
Max Drawdown (1Y)Largest decline over 1 year | -9.68% | -8.14% | -1.54% |
Current DrawdownCurrent decline from peak | -3.07% | -1.66% | -1.41% |
Average DrawdownAverage peak-to-trough decline | -6.72% | -1.78% | -4.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.78% | 2.88% | +0.90% |
Volatility
JDOC vs. XLVI - Volatility Comparison
Jpmorgan Healthcare Leaders ETF (JDOC) has a higher volatility of 4.64% compared to State Street Health Care Select Sector SPDR Premium Income ETF (XLVI) at 3.36%. This indicates that JDOC's price experiences larger fluctuations and is considered to be riskier than XLVI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JDOC | XLVI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.64% | 3.36% | +1.28% |
Volatility (6M)Calculated over the trailing 6-month period | 11.60% | 8.73% | +2.87% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.82% | 10.75% | +4.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.69% | 11.04% | +3.65% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 14.69% | 11.04% | +3.65% |
JDOC vs. XLVI - Expense Ratio Comparison
JDOC has a 0.65% expense ratio, which is higher than XLVI's 0.35% expense ratio.
Dividends
JDOC vs. XLVI - Dividend Comparison
JDOC's dividend yield for the trailing twelve months is around 0.85%, less than XLVI's 12.76% yield.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
JDOC Jpmorgan Healthcare Leaders ETF | 0.85% | 0.89% | 5.57% | 0.15% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 12.76% | 5.73% | 0.00% | 0.00% |
Frequently Asked Questions
JDOC and XLVI have a correlation of 0.88, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JDOC has higher volatility (4.64%) compared to XLVI (3.36%). In terms of maximum drawdown, JDOC dropped -20.87% vs XLVI's -8.14%.
On 1-year performance, JDOC leads with 23.57% vs 22.96% for XLVI. On fees, XLVI is cheaper at 0.35% per year. On volatility, XLVI has been the lower-risk option at 3.36%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, JDOC has performed better with a 23.57% return vs 22.96%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XLVI is cheaper with a 0.35% expense ratio, compared with 0.65% for JDOC.
XLVI has the higher dividend yield at 12.76%, compared with 0.85% for JDOC.
JDOC is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: JPMorgan and State Street. Their fees differ too: 0.65% for JDOC and 0.35% for XLVI.
XLVI currently has the higher Sharpe Ratio (2.15 vs 1.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JDOC and XLVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer